Source: Resumos (e-Book ). Conference titles: International Congress of the Brazilian Genetics Society. Unidade: FMRP
Subjects: EXPRESSÃO GÊNICA, APOPTOSE, HIV, SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA, ANTI-HIV
ABNT
CANDIDO, Marina Ferreira et al. Exploring blood-brain barrier-crossing drugs for the identification of novel therapies in pediatric medulloblastoma. 2024, Anais.. Ribeirão Preto: Sociedade Brasileira de Genética (SBG), 2024. Disponível em: https://www.sbg.org.br/admin/files/book/book_bcovOe2cEJzf.pdf. Acesso em: 09 fev. 2026.APA
Candido, M. F., Baptistella, M. M., Pereira, E. A. da S., Panepucci, R. A., Valera, E. T., & Scrideli, C. A. (2024). Exploring blood-brain barrier-crossing drugs for the identification of novel therapies in pediatric medulloblastoma. In Resumos (e-Book ). Ribeirão Preto: Sociedade Brasileira de Genética (SBG). Recuperado de https://www.sbg.org.br/admin/files/book/book_bcovOe2cEJzf.pdfNLM
Candido MF, Baptistella MM, Pereira EA da S, Panepucci RA, Valera ET, Scrideli CA. Exploring blood-brain barrier-crossing drugs for the identification of novel therapies in pediatric medulloblastoma [Internet]. Resumos (e-Book ). 2024 ;[citado 2026 fev. 09 ] Available from: https://www.sbg.org.br/admin/files/book/book_bcovOe2cEJzf.pdfVancouver
Candido MF, Baptistella MM, Pereira EA da S, Panepucci RA, Valera ET, Scrideli CA. Exploring blood-brain barrier-crossing drugs for the identification of novel therapies in pediatric medulloblastoma [Internet]. Resumos (e-Book ). 2024 ;[citado 2026 fev. 09 ] Available from: https://www.sbg.org.br/admin/files/book/book_bcovOe2cEJzf.pdf
